BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 35511742)

  • 1. Association of Blood Pressure with Prostate Cancer Risk by Disease Severity and Prostate Cancer Death: A Pooled Cohort Study.
    Jochems SHJ; Häggström C; Stattin P; Järvholm B; Stocks T
    Cancer Epidemiol Biomarkers Prev; 2022 Jul; 31(7):1483-1491. PubMed ID: 35511742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systolic and diastolic blood pressure, prostate cancer risk, treatment, and survival. The PROCA-life study.
    Stikbakke E; Schirmer H; Knutsen T; Støyten M; Wilsgaard T; Giovannucci EL; McTiernan A; Eggen AE; Haugnes HS; Richardsen E; Thune I
    Cancer Med; 2022 Feb; 11(4):1005-1015. PubMed ID: 34939344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smoking and Risk of Prostate Cancer and Prostate Cancer Death: A Pooled Study.
    Jochems SHJ; Fritz J; Häggström C; Järvholm B; Stattin P; Stocks T
    Eur Urol; 2023 May; 83(5):422-431. PubMed ID: 35523620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
    Hammarsten J; Högstedt B
    Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Treatment With 5α-Reductase Inhibitors With Time to Diagnosis and Mortality in Prostate Cancer.
    Sarkar RR; Parsons JK; Bryant AK; Ryan ST; Kader AK; McKay RR; D'Amico AV; Nguyen PL; Hulley BJ; Einck JP; Mundt AJ; Kane CJ; Murphy JD; Rose BS
    JAMA Intern Med; 2019 Jun; 179(6):812-819. PubMed ID: 31058923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood pressure and risk of prostate cancer: Cohort Norway (CONOR).
    Martin RM; Vatten L; Gunnell D; Romundstad P
    Cancer Causes Control; 2010 Mar; 21(3):463-72. PubMed ID: 19949849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between Antidiabetic Medications and Prostate-Specific Antigen Levels and Biopsy Results.
    Beckmann K; Crawley D; Nordström T; Aly M; Olsson H; Lantz A; Binti Abd Jalal N; Garmo H; Adolfsson J; Eklund M; Van Hemelrijck M
    JAMA Netw Open; 2019 Nov; 2(11):e1914689. PubMed ID: 31693126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretreatment PSA velocity and risk of death from prostate cancer following external beam radiation therapy.
    D'Amico AV; Renshaw AA; Sussman B; Chen MH
    JAMA; 2005 Jul; 294(4):440-7. PubMed ID: 16046650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abdominal obesity, hypertension, antihypertensive medication use and biochemical recurrence of prostate cancer after radical prostatectomy.
    Ohwaki K; Endo F; Hattori K
    Eur J Cancer; 2015 Mar; 51(5):604-9. PubMed ID: 25613441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving Clinical Risk Stratification at Diagnosis in Primary Prostate Cancer: A Prognostic Modelling Study.
    Gnanapragasam VJ; Lophatananon A; Wright KA; Muir KR; Gavin A; Greenberg DC
    PLoS Med; 2016 Aug; 13(8):e1002063. PubMed ID: 27483464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radical prostatectomy versus deferred treatment for localised prostate cancer.
    Vernooij RW; Lancee M; Cleves A; Dahm P; Bangma CH; Aben KK
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD006590. PubMed ID: 32495338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ejaculation Frequency and Risk of Prostate Cancer: Updated Results with an Additional Decade of Follow-up.
    Rider JR; Wilson KM; Sinnott JA; Kelly RS; Mucci LA; Giovannucci EL
    Eur Urol; 2016 Dec; 70(6):974-982. PubMed ID: 27033442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between Lead Time and Prostate Cancer Grade: Evidence of Grade Progression from Long-term Follow-up of Large Population-based Cohorts Not Subject to Prostate-specific Antigen Screening.
    Assel M; Dahlin A; Ulmert D; Bergh A; Stattin P; Lilja H; Vickers AJ
    Eur Urol; 2018 Jun; 73(6):961-967. PubMed ID: 29066048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early versus deferred standard androgen suppression therapy for advanced hormone-sensitive prostate cancer.
    Kunath F; Jensen K; Pinart M; Kahlmeyer A; Schmidt S; Price CL; Lieb V; Dahm P
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD003506. PubMed ID: 31194882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Definition and Impact on Oncologic Outcomes of Persistently Elevated Prostate-specific Antigen After Salvage Lymph Node Dissection for Node-only Recurrent Prostate Cancer After Radical Prostatectomy: Clinical Implications for Multimodal Therapy.
    Bravi CA; Droghetti M; Fossati N; Gandaglia G; Suardi N; Mazzone E; Cucchiara V; Scuderi S; Barletta F; Schiavina R; Osmonov D; Juenemann KP; Boeri L; Karnes RJ; Kretschmer A; Buchner A; Stief C; Hiester A; Nini A; Albers P; Devos G; Joniau S; Van Poppel H; Grubmüller B; Shariat SF; Heidenreich A; Pfister D; Tilki D; Graefen M; Gill IS; Mottrie A; Karakiewicz PI; Montorsi F; Briganti A
    Eur Urol Oncol; 2022 Jun; 5(3):285-295. PubMed ID: 34176768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time to castration-resistant prostate cancer and prostate cancer death according to PSA response in men with non-metastatic prostate cancer treated with gonadotropin releasing hormone agonists.
    Bonde TM; Westerberg M; Aly M; Eklund M; Adolfsson J; Bill-Axelson A; Garmo H; Stattin P; Robinson D
    Scand J Urol; 2022 Jun; 56(3):169-175. PubMed ID: 35548951
    [No Abstract]   [Full Text] [Related]  

  • 17. Body mass index in relation to serum prostate-specific antigen levels and prostate cancer risk.
    Bonn SE; Sjölander A; Tillander A; Wiklund F; Grönberg H; Bälter K
    Int J Cancer; 2016 Jul; 139(1):50-7. PubMed ID: 26914149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between one-time prostate-specific antigen (PSA) test with free/total PSA ratio and prostate cancer mortality: A 30-year prospective cohort study.
    Lundgren PO; Kjellman A; Norming U; Gustafsson O
    BJU Int; 2021 Oct; 128(4):490-496. PubMed ID: 33811738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early detection of high-grade prostate cancer using digital rectal examination (DRE) in men with a prostate-specific antigen level of <2.5 ng/mL and the risk of death.
    Hattangadi JA; Chen MH; D'Amico AV
    BJU Int; 2012 Dec; 110(11):1636-41. PubMed ID: 22757982
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.